NeuroLife Advantage, Inc. – Trademark Portfolio

Entity Type: 03

NeuroLife Advantage, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 29 (Meats & Processed Foods) — 7 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 4 Nice Classification classes. The owner is based in Los Angeles, CA.

Suite 300

5230 Pacific Concourse Drive

Los Angeles, CA 90045

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

NeuroLife Advantage, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

29
Meats & Processed Foods (7 filings)

Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits

32
Light Beverages (6 filings)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (5 filings)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does NeuroLife Advantage, Inc. have?

NeuroLife Advantage, Inc. has 8 U.S. trademarks filed with the USPTO.

What trademark classes does NeuroLife Advantage, Inc. file in?

NeuroLife Advantage, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 29 (Meats & Processed Foods), Class 32 (Light Beverages), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 29 covers meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits.

What is NeuroLife Advantage, Inc.'s trademark registration success rate?

NeuroLife Advantage, Inc. has a 0% trademark registration rate, with 0 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.